Manufacturer copay assistance · AmBisome (J0289) · Astellas Pharma
$0 — free drug… · Maximum benefit Unlimited within the course of prescribed therapy — Astellas ships replacement drug directly to the provider office/clinic · Product-replacement model: provider acquires and administers AmBisome to the patient (outpatient/infusion/home-health setting), then submits a pre-screened application; Astellas ships replacement product to the provider. Does NOT cover administration fees or office visits — patient still owes those separately.
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
Run a benefits estimate for AmBisome — the program's cap applies against the patient share CareCost calculates.
Yes — AmBisome Stock Replacement Program (Astellas Pharma Support Solutions) from Astellas Pharma. $0 — free drug replacement to provider; patient pays no out-of-pocket for the AmBisome drug itself. Commercial insurance is typically required.
$0 — free drug replacement to provider; patient pays no out-of-pocket for the AmBisome drug itself Maximum benefit: Unlimited within the course of prescribed therapy — Astellas ships replacement drug directly to the provider office/clinic. Product-replacement model: provider acquires and administers AmBisome to the patient (outpatient/infusion/home-health setting), then submits a pre-screened application; Astellas ships replacement product to the provider. Does NOT cover administration fees or office visits — patient still owes those separately.
Accepted insurance: uninsured. Income limit: Income and insurance criteria are not publicly disclosed; Astellas requires the doctor/social worker/physician-office staff to call 800-477-6472 to pre-screen the patient before enrollment. Astellas' parallel CRESEMBA Patient Assistance Program (same general APSS framework) is described as 'for uninsured patients' with no published FPL number — the AmBisome Stock Replacement Program follows the same template..